US Stock MarketDetailed Quotes

NBY NovaBay Pharmaceuticals

Watchlist
  • 0.5668
  • +0.0269+4.98%
Close Dec 26 16:00 ET
  • 0.6063
  • +0.0395+6.97%
Post 20:01 ET
2.77MMarket Cap-0.01P/E (TTM)

NovaBay Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-219.04%-2.06M
66.12%-578K
-32.43%-1.57M
37.92%-4.13M
51.03%-592K
61.75%-646K
-0.41%-1.71M
42.29%-1.19M
27.61%-6.65M
72.00%-1.21M
Net income from continuing operations
10.42%-1.21M
8.28%-1.59M
-129.74%-3.09M
9.13%-9.64M
36.46%-5.21M
-894.85%-1.35M
19.81%-1.73M
-1,111.71%-1.35M
-82.14%-10.61M
-5,093.67%-8.21M
Operating gains losses
--0
--232K
--606K
99.43%-20K
94.98%-49K
--0
----
----
23.42%-3.52M
78.85%-976K
Depreciation and amortization
0.00%95K
16.99%179K
-7.69%12K
-57.97%203K
-147.15%-58K
-20.17%95K
27.50%153K
-89.26%13K
305.88%483K
41.38%123K
Other non cash items
-78.10%145K
--311K
--783K
401.25%1.69M
266.96%571K
--662K
----
----
---561K
---342K
Change In working capital
-891.96%-1.11M
133.77%230K
-18.57%57K
40.71%750K
13.39%1.47M
88.48%-112K
-474.18%-681K
191.67%70K
1,502.63%533K
1,723.75%1.3M
-Change in receivables
-111.26%-157K
125.58%187K
-121.60%-54K
498.03%1.21M
88.13%301K
234.69%1.39M
-160.82%-731K
139.56%250K
-167.48%-305K
-15.34%160K
-Change in inventory
299.12%227K
-3,600.00%-37K
-33.75%-107K
358.06%560K
19.65%755K
57.30%-114K
93.75%-1K
85.84%-80K
10.70%-217K
434.75%631K
-Change in prepaid assets
-143.03%-71K
405.26%116K
-155.56%-115K
-21.10%172K
662.50%90K
94.12%165K
-130.89%-38K
-273.08%-45K
519.23%218K
-155.17%-16K
-Change in payables and accrued expense
32.03%-989K
-37.92%149K
516.22%308K
-273.61%-1.16M
-75.70%131K
-1,965.38%-1.46M
121.20%240K
-106.26%-74K
509.20%667K
226.82%539K
-Change in other current assets
-260.00%-18K
-43.10%-83K
60.38%85K
128.07%400K
301.96%410K
-101.79%-5K
-147.54%-58K
102.75%53K
-5,800.00%-1.43M
142.32%102K
-Change in other current liabilities
-6.19%-103K
-9.68%-102K
-76.47%-60K
-127.46%-438K
-82.91%-214K
13.39%-97K
20.51%-93K
-101.75%-34K
2,898.25%1.6M
-146.80%-117K
Cash from discontinued investing activities
Operating cash flow
-219.04%-2.06M
66.12%-578K
-32.43%-1.57M
37.92%-4.13M
51.03%-592K
61.75%-646K
-0.41%-1.71M
42.29%-1.19M
27.61%-6.65M
72.00%-1.21M
Investing cash flow
Cash flow from continuing investing activities
-100.00%-2K
0.00%-2K
8,315.38%1.07M
83.04%-19K
-3K
98.75%-1K
75.00%-2K
45.83%-13K
99.07%-112K
0
Net PPE purchase and sale
-100.00%-2K
0.00%-2K
84.62%-2K
83.04%-19K
---3K
98.75%-1K
75.00%-2K
45.83%-13K
-115.38%-112K
--0
Net business purchase and sale
--0
--0
--1.07M
----
----
--0
--0
--0
----
----
Cash from discontinued investing activities
Investing cash flow
-100.00%-2K
0.00%-2K
8,315.38%1.07M
83.04%-19K
---3K
98.75%-1K
75.00%-2K
45.83%-13K
99.07%-112K
--0
Financing cash flow
Cash flow from continuing financing activities
462.05%2.09M
-119.58%-492K
-597K
-58.77%1.91M
-100.86%-26K
-133.88%-577K
2.51M
0
-72.40%4.63M
-79.49%3.04M
Net issuance payments of debt
-36.92%-790K
-122.16%-622K
---578K
1,553.33%1.53M
---704K
---577K
--2.81M
--0
-200.00%-105K
--0
Net preferred stock issuance
----
----
----
--0
----
----
----
----
-79.64%3.04M
----
Proceeds from stock option exercised by employees
--21K
----
----
-66.82%565K
--565K
--0
----
----
--1.7M
--0
Net other financing activities
--0
---96K
---19K
---181K
--113K
--0
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
462.05%2.09M
-119.58%-492K
---597K
-58.77%1.91M
-100.86%-26K
-133.88%-577K
--2.51M
--0
-72.40%4.63M
-79.49%3.04M
Net cash flow
Beginning cash position
-74.83%1.23M
-44.87%2.3M
-38.32%3.61M
-26.73%5.85M
-9.08%3.66M
19.29%4.87M
-28.02%4.17M
-26.73%5.85M
-35.79%7.98M
-57.70%4.02M
Current changes in cash
102.76%26K
-260.48%-1.07M
19.52%-1.31M
-5.02%-2.24M
-118.73%-342K
-1,327.27%-942K
139.13%668K
25.71%-1.62M
52.05%-2.13M
219.82%1.83M
End cash Position
-65.72%1.25M
-74.83%1.23M
-44.87%2.3M
-38.32%3.61M
-38.32%3.61M
-9.08%3.66M
19.29%4.87M
-28.02%4.17M
-26.73%5.85M
-26.73%5.85M
Free cash flow
-218.86%-2.06M
66.04%-580K
-31.17%-1.57M
38.66%-4.15M
50.79%-595K
63.43%-647K
-0.06%-1.71M
42.34%-1.2M
26.81%-6.77M
72.05%-1.21M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -219.04%-2.06M66.12%-578K-32.43%-1.57M37.92%-4.13M51.03%-592K61.75%-646K-0.41%-1.71M42.29%-1.19M27.61%-6.65M72.00%-1.21M
Net income from continuing operations 10.42%-1.21M8.28%-1.59M-129.74%-3.09M9.13%-9.64M36.46%-5.21M-894.85%-1.35M19.81%-1.73M-1,111.71%-1.35M-82.14%-10.61M-5,093.67%-8.21M
Operating gains losses --0--232K--606K99.43%-20K94.98%-49K--0--------23.42%-3.52M78.85%-976K
Depreciation and amortization 0.00%95K16.99%179K-7.69%12K-57.97%203K-147.15%-58K-20.17%95K27.50%153K-89.26%13K305.88%483K41.38%123K
Other non cash items -78.10%145K--311K--783K401.25%1.69M266.96%571K--662K-----------561K---342K
Change In working capital -891.96%-1.11M133.77%230K-18.57%57K40.71%750K13.39%1.47M88.48%-112K-474.18%-681K191.67%70K1,502.63%533K1,723.75%1.3M
-Change in receivables -111.26%-157K125.58%187K-121.60%-54K498.03%1.21M88.13%301K234.69%1.39M-160.82%-731K139.56%250K-167.48%-305K-15.34%160K
-Change in inventory 299.12%227K-3,600.00%-37K-33.75%-107K358.06%560K19.65%755K57.30%-114K93.75%-1K85.84%-80K10.70%-217K434.75%631K
-Change in prepaid assets -143.03%-71K405.26%116K-155.56%-115K-21.10%172K662.50%90K94.12%165K-130.89%-38K-273.08%-45K519.23%218K-155.17%-16K
-Change in payables and accrued expense 32.03%-989K-37.92%149K516.22%308K-273.61%-1.16M-75.70%131K-1,965.38%-1.46M121.20%240K-106.26%-74K509.20%667K226.82%539K
-Change in other current assets -260.00%-18K-43.10%-83K60.38%85K128.07%400K301.96%410K-101.79%-5K-147.54%-58K102.75%53K-5,800.00%-1.43M142.32%102K
-Change in other current liabilities -6.19%-103K-9.68%-102K-76.47%-60K-127.46%-438K-82.91%-214K13.39%-97K20.51%-93K-101.75%-34K2,898.25%1.6M-146.80%-117K
Cash from discontinued investing activities
Operating cash flow -219.04%-2.06M66.12%-578K-32.43%-1.57M37.92%-4.13M51.03%-592K61.75%-646K-0.41%-1.71M42.29%-1.19M27.61%-6.65M72.00%-1.21M
Investing cash flow
Cash flow from continuing investing activities -100.00%-2K0.00%-2K8,315.38%1.07M83.04%-19K-3K98.75%-1K75.00%-2K45.83%-13K99.07%-112K0
Net PPE purchase and sale -100.00%-2K0.00%-2K84.62%-2K83.04%-19K---3K98.75%-1K75.00%-2K45.83%-13K-115.38%-112K--0
Net business purchase and sale --0--0--1.07M----------0--0--0--------
Cash from discontinued investing activities
Investing cash flow -100.00%-2K0.00%-2K8,315.38%1.07M83.04%-19K---3K98.75%-1K75.00%-2K45.83%-13K99.07%-112K--0
Financing cash flow
Cash flow from continuing financing activities 462.05%2.09M-119.58%-492K-597K-58.77%1.91M-100.86%-26K-133.88%-577K2.51M0-72.40%4.63M-79.49%3.04M
Net issuance payments of debt -36.92%-790K-122.16%-622K---578K1,553.33%1.53M---704K---577K--2.81M--0-200.00%-105K--0
Net preferred stock issuance --------------0-----------------79.64%3.04M----
Proceeds from stock option exercised by employees --21K---------66.82%565K--565K--0----------1.7M--0
Net other financing activities --0---96K---19K---181K--113K--0----------------
Cash from discontinued financing activities
Financing cash flow 462.05%2.09M-119.58%-492K---597K-58.77%1.91M-100.86%-26K-133.88%-577K--2.51M--0-72.40%4.63M-79.49%3.04M
Net cash flow
Beginning cash position -74.83%1.23M-44.87%2.3M-38.32%3.61M-26.73%5.85M-9.08%3.66M19.29%4.87M-28.02%4.17M-26.73%5.85M-35.79%7.98M-57.70%4.02M
Current changes in cash 102.76%26K-260.48%-1.07M19.52%-1.31M-5.02%-2.24M-118.73%-342K-1,327.27%-942K139.13%668K25.71%-1.62M52.05%-2.13M219.82%1.83M
End cash Position -65.72%1.25M-74.83%1.23M-44.87%2.3M-38.32%3.61M-38.32%3.61M-9.08%3.66M19.29%4.87M-28.02%4.17M-26.73%5.85M-26.73%5.85M
Free cash flow -218.86%-2.06M66.04%-580K-31.17%-1.57M38.66%-4.15M50.79%-595K63.43%-647K-0.06%-1.71M42.34%-1.2M26.81%-6.77M72.05%-1.21M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion with Explanatory Notes--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Adobe
ADBE
+0.50%
Lennar Corp
LEN
+0.46%
Petroleo Brasileiro SA Petrobras
PBR
+0.46%
Apple
AAPL
+0.32%
D.R. Horton
DHI
+0.30%

Unlock the Full List